Single‐cell detection of DMSO promoted HL‐60 differentiation toward granulocyte based on DC‐iDEP for medicine screening
Biotechnology Journal · 2023
DOI: 10.1002/biot.202300073 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology Journal, 2023. Verfasst von Miaomiao Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin, China. Hauptthemen laut MEDLINE: Dimethyl Sulfoxide, Leukemia, Myeloid, Acute. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Tianjin Municipal Science and Technology Bureau, State Key Program of National Natural Science Foundation of China.
Abstract (Originalsprache)
The most common form of leukemia in adults is acute leukemia. Drug differentiation control is an extremely critical treatment for acute leukemia. Unfortunately, current techniques detecting differentiation control experience long time and complex steps of verification hindering the pace of medicine discovery: flow cytometry and RT‐PCR are highly accurate and efficient at a cost of inconvenient fluorescent labeling or a high risk of contamination; conventional staining leads to cell death unavailable for further pharmacological tests. There is a great interest in developing simple, fast, and non‐invasive techniques to screen medicine. DC‐iDEP is an emerging label‐free identification technique taking advantage of the whole cell native biophysical property for sorting cell populations. Here, HL‐60 cell line has been used as a model to study the differentiation process toward granulocytes and medicine efficacy. The results showed that DEP succeeded in detecting the DMSO promoted HL‐60 differentiation degree by the weighted average characterization factor. This factor is related to the single cell biophysical property, which accumulates to generate differences in each population with distinct constitutions. Furthermore, cichoric acid was investigated to be capable of promoting DMSO‐induced differentiation efficiently. Using the change induced by cichoric acid, the HL‐60 medicine screening application has been first attempted based on DEP. A rapid, label‐free medicine screening method has been established to monitor HL‐60 differentiation toward granulocyte and has great potential for medicine screening.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
- State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
- Pharmaceutical Sciences, Toho University, Funabashi, Chiba, Japan.
- College of Pharmaceutical, Engineering of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
ORCID-Profile: Yameng Liu
Förderung
- Tianjin Municipal Science and Technology Bureau
- State Key Program of National Natural Science Foundation of China
Zitieren
APA
Wang, M., Wang, M., Li, W., Liu, Y., & Qiu, F. (2023). Single‐cell detection of DMSO promoted HL‐60 differentiation toward granulocyte based on DC‐iDEP for medicine screening. Biotechnology Journal. https://doi.org/10.1002/biot.202300073
Vancouver
Wang M, Wang M, Li W, Liu Y, Qiu F. Single‐cell detection of DMSO promoted HL‐60 differentiation toward granulocyte based on DC‐iDEP for medicine screening. Biotechnology Journal. 2023. doi:10.1002/biot.202300073
BibTeX
@article{Wang2023,
author = {Wang, Miaomiao and Wang, Mingxu and Li, Wei and Liu, Yameng and Qiu, Feng},
title = {Single‐cell detection of DMSO promoted HL‐60 differentiation toward granulocyte based on DC‐iDEP for medicine screening},
journal = {Biotechnology Journal},
year = {2023},
doi = {10.1002/biot.202300073}
}
EUVIMED